Genistein also decreased hepatic fatty acid synthase activity [10] and increased the expression of peroxisome proliferator-activated receptor-gamma (PPARγ) [11] in NASH. This evidence concerns the gene PPARG and metabolic dysfunction-associated steatohepatitis.